{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:05:16Z","timestamp":1777395916342,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,12,12]]},"DOI":"10.3233\/jad-190791","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T08:19:57Z","timestamp":1573633197000},"page":"1313-1322","source":"Crossref","is-referenced-by-count":9,"title":["Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"72","author":[{"given":"Jianping","family":"Jia","sequence":"first","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital University of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Cognitive Disorder, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Disease, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[{"name":"China National Clinical Research Center for Neurological Disease, Beijing, China"},{"name":"Movement Disorders Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Union Hospital of Fujian Medical University, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dantao","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Kuang","sequence":"additional","affiliation":[{"name":"Mental Health Center, West China Hospital of Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihou","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenshi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Huadong Hospital, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yansheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifu","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Geriatric Psychiatry, Alzheimer\u2019s Disease and Related Disorders\u2019 Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190791_ref1","volume-title":"World Alzheimer Report 2015. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends","author":"Prince","year":"2015"},{"key":"10.3233\/JAD-190791_ref2","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/S0140-6736(13)60221-4","article-title":"Epidemiology of Alzheimer\u2019s disease and other forms of dementia in China, 1990-2010: A systematic review and analysis","volume":"381","author":"Chan","year":"2013","journal-title":"Lancet"},{"key":"10.3233\/JAD-190791_ref3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","article-title":"The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide","volume":"14","author":"Jia","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190791_ref4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.18632\/aging.101827","article-title":"Potential role of miRNA-140 in Alzheimer\u2019s disease","volume":"11","author":"Akhter","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.3233\/JAD-190791_ref5","doi-asserted-by":"crossref","first-page":"38452","DOI":"10.1038\/srep38452","article-title":"VRK3-mediated nuclear localization of HSP70 prevents glutamate excitotoxicity-induced apoptosis and Abeta accumulation via enhancement of ERK phosphatase VHR activity","volume":"6","author":"Song","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-190791_ref6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/brain\/awy040","article-title":"Cognitive ageing and Alzheimer\u2019s disease: The cholinergic system redux","volume":"141","author":"Sultzer","year":"2018","journal-title":"Brain"},{"key":"10.3233\/JAD-190791_ref7","doi-asserted-by":"crossref","first-page":"PCC.12r01412","DOI":"10.4088\/PCC.12r01412","article-title":"A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease","volume":"15","author":"Nordberg","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.3233\/JAD-190791_ref8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1468-1331.2010.03040.x","article-title":"EFNS guidelines for the diagnosis and management of Alzheimer\u2019s disease","volume":"17","author":"Hort","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-190791_ref9","volume-title":"Dementia: Assessment, management and support for people living with dementia and their carers","author":"UK","year":"2018"},{"key":"10.3233\/JAD-190791_ref10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cpt.1104","article-title":"Monotherapy is good enough for patients with mild-to-moderate Alzheimer\u2019s disease: A network meta-analysis of 76 randomized controlled trials","volume":"105","author":"Tsoi","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.3233\/JAD-190791_ref11","first-page":"CD001191","article-title":"Rivastigmine for Alzheimer\u2019s disease","author":"Birks","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-190791_ref12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","article-title":"Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: A network meta-analysis of 41 randomized controlled trials","volume":"10","author":"Dou","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190791_ref13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000345279","article-title":"Persistence of cholinesterase inhibitor treatment in dementia: Insights from a naturalistic study","volume":"3","author":"Olazaran","year":"2013","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.3233\/JAD-190791_ref16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0149-2918(98)80127-6","article-title":"Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Polinsky","year":"1998","journal-title":"Clin Ther"},{"key":"10.3233\/JAD-190791_ref17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1586\/14737175.2015.1068120","article-title":"Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer\u2019s disease: A meta-analysis","volume":"15","author":"Su","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-190791_ref18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1533317510365344","article-title":"Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer\u2019s disease","volume":"25","author":"Farlow","year":"2010","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-190791_ref19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.2008.01086.x","article-title":"Long-term rivastigmine treatment in a routine clinical setting","volume":"119","author":"Minthon","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-190791_ref20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1185\/030079904X6273","article-title":"An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting","volume":"20","author":"Aguglia","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.3233\/JAD-190791_ref21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1185\/030079902125000471","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer\u2019s disease who failed to benefit from treatment with donepezil","volume":"18","author":"Auriacombe","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.3233\/JAD-190791_ref22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1185\/030079905X65655","article-title":"Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer\u2019s disease","volume":"21","author":"Bartorelli","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.3233\/JAD-190791_ref23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3233\/JAD-180005","article-title":"Behavioral and neuropsychiatric disorders in Alzheimer\u2019s disease","volume":"63","author":"Cortes","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190791_ref24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-190791_ref25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.3233\/JAD-190791_ref26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cbi.2012.08.009","article-title":"Butyrylcholinesterase radioligands to image Alzheimer\u2019s disease brain","volume":"203","author":"Darvesh","year":"2013","journal-title":"Chem Biol Interact"},{"key":"10.3233\/JAD-190791_ref27","doi-asserted-by":"crossref","first-page":"2320.e15","DOI":"10.1016\/j.neurobiolaging.2010.04.028","article-title":"Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer\u2019s disease in the brain in vivo","volume":"32","author":"Darreh-Shori","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190791_ref28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JAD-131190","article-title":"Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer\u2019s disease: A 12-month, randomized, open-label trial","volume":"39","author":"Cumbo","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190791_ref29","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"10.3233\/JAD-190791_ref30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.clpt.6100242","article-title":"Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer\u2019s disease patients","volume":"83","author":"Lefevre","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.3233\/JAD-190791_ref31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WAD.0b013e3181f32829","article-title":"Effects of body weight on tolerability of rivastigmine transdermal patch: A post-hoc analysis of a double-blind trial in patients with Alzheimer disease","volume":"25","author":"Lee","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-190791_ref32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/cns.12521","article-title":"Rivastigmine patch in Chinese patients with probable Alzheimer\u2019s disease: A 24-week, randomized, double-blind parallel-group study comparing rivastigmine patch (9.5 mg\/24 h) with capsule (6 mg twice daily)","volume":"22","author":"Zhang","year":"2016","journal-title":"CNS Neurosci Ther"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:07Z","timestamp":1777370827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":30,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-190791","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}